blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3996673

EP3996673 - A METHOD FOR THE PREPARATION OF A GEL-FORMING COMPOSITION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.08.2024
Database last updated on 03.10.2024
FormerThe patent has been granted
Status updated on  25.08.2023
FormerGrant of patent is intended
Status updated on  08.06.2023
FormerExamination is in progress
Status updated on  09.12.2022
FormerRequest for examination was made
Status updated on  15.04.2022
FormerThe international publication has been made
Status updated on  18.01.2021
Formerunknown
Status updated on  11.07.2020
Most recent event   Tooltip02.08.2024No opposition filed within time limitpublished on 04.09.2024  [2024/36]
Applicant(s)For all designated states
TheraVet SA
Bâtiment Biotech 3
Avenue Jean Mermoz 32/ 1
6041 Charleroi / BE
[2022/19]
Inventor(s)01 / BASTIANELLI, Enrico
41, Avenue de la Libération
1640 Rhode-Saint-Genèse / BE
02 / WINAND, Julie
2 rue aux Ruwales
5024 Marche les Dames / BE
03 / ENA, Sabrina
75, Rue de Marchienne
6110 Montigny le Tilleul / BE
04 / ZEIPPEN, Caroline
6, Chemin de Barsy
5370 Flostoy / BE
 [2022/19]
Representative(s)Brantsandpatents bv
Pauline Van Pottelsberghelaan 24
9051 Ghent / BE
[2023/39]
Former [2022/19]Brantsandpatents bvba
Pauline Van Pottelsberghelaan 24
9051 Ghent / BE
Application number, filing date20735622.107.07.2020
[2022/20]
WO2020EP69142
Priority number, dateEP2019018493608.07.2019         Original published format: EP 19184936
[2022/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021005069
Date:14.01.2021
Language:EN
[2021/02]
Type: A1 Application with search report 
No.:EP3996673
Date:18.05.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 14.01.2021 takes the place of the publication of the European patent application.
[2022/20]
Type: B1 Patent specification 
No.:EP3996673
Date:27.09.2023
Language:EN
[2023/39]
Search report(s)International search report - published on:EP14.01.2021
ClassificationIPC:A61K9/06, A61K9/00, A61K47/02, A61P19/00, A61K31/4168, A61K31/728, A61K33/06, A61K35/16, A61L27/36, A61L27/52, A61L27/54
[2023/23]
CPC:
A61L27/52 (EP,IL); A61K9/06 (EP,CN,IL); A61K9/08 (US);
A61K31/4168 (EP,CN,IL,US); A61K31/728 (EP,IL); A61K33/06 (EP,IL);
A61K33/14 (US); A61K33/42 (US); A61K35/16 (EP,CN,IL);
A61K45/06 (CN,IL); A61K47/02 (EP,CN,IL); A61K47/18 (US);
A61K47/36 (CN,IL,US); A61K47/46 (US); A61K9/0024 (EP,IL);
A61L27/3616 (EP,IL); A61L27/54 (EP,IL); A61P19/00 (EP,IL);
A61P19/02 (CN,IL); A61P19/04 (CN,IL); A61P19/08 (CN,IL);
A61P29/00 (CN,IL); A61K2300/00 (IL); A61L2300/414 (EP,IL);
A61L2400/06 (EP,IL); A61L2430/02 (EP,IL); A61L2430/06 (EP,IL);
A61L2430/10 (EP,IL) (-)
C-Set:
A61K31/4168, A61K2300/00 (EP,CN);
A61K31/728, A61K2300/00 (EP);
A61K33/06, A61K2300/00 (EP);
A61K35/16, A61K2300/00 (CN,EP)
Former IPC [2022/19]A61K9/00, A61K9/06, A61K31/00, A61K35/00, A61K47/02, A61L27/00, A61P19/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/19]
Extension statesBA12.01.2022
ME12.01.2022
Validation statesKH12.01.2022
MA12.01.2022
MD12.01.2022
TN12.01.2022
TitleGerman:VERFAHREN ZUR HERSTELLUNG EINER GELBILDENDEN ZUSAMMENSETZUNG[2022/19]
English:A METHOD FOR THE PREPARATION OF A GEL-FORMING COMPOSITION[2022/19]
French:PROCÉDÉ DE PRÉPARATION D'UNE COMPOSITION DE FORMATION DE GEL[2023/23]
Former [2022/19]PROCÉDÉ DE PRÉPARATION D'UNE COMPOSITION GÉLIFIANTE
Entry into regional phase12.01.2022National basic fee paid 
12.01.2022Designation fee(s) paid 
12.01.2022Examination fee paid 
Examination procedure30.04.2021Request for preliminary examination filed
International Preliminary Examining Authority: EP
12.01.2022Examination requested  [2022/20]
12.01.2022Date on which the examining division has become responsible
13.12.2022Despatch of a communication from the examining division (Time limit: M04)
02.03.2023Reply to a communication from the examining division
09.06.2023Communication of intention to grant the patent
17.08.2023Fee for grant paid
17.08.2023Fee for publishing/printing paid
17.08.2023Receipt of the translation of the claim(s)
Opposition(s)28.06.2024No opposition filed within time limit [2024/36]
Fees paidRenewal fee
09.02.2022Renewal fee patent year 03
26.07.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ27.09.2023
EE27.09.2023
HR27.09.2023
LT27.09.2023
LV27.09.2023
PL27.09.2023
RO27.09.2023
RS27.09.2023
SK27.09.2023
SM27.09.2023
GR28.12.2023
IS27.01.2024
[2024/26]
Former [2024/23]CZ27.09.2023
EE27.09.2023
HR27.09.2023
LT27.09.2023
LV27.09.2023
RO27.09.2023
RS27.09.2023
SK27.09.2023
SM27.09.2023
GR28.12.2023
IS27.01.2024
Former [2024/20]HR27.09.2023
LT27.09.2023
LV27.09.2023
RS27.09.2023
SM27.09.2023
GR28.12.2023
IS27.01.2024
Former [2024/11]HR27.09.2023
LT27.09.2023
LV27.09.2023
RS27.09.2023
GR28.12.2023
Former [2024/08]LT27.09.2023
GR28.12.2023
Cited inInternational search[Y]WO2009016451  (BIOTECHNOLOGY INST I MAS D SL [ES]) [Y] 1-15 * page 1, lines 10-11 * * page 4, lines 33-35 * * page 5, lines 1-4 * * page 8, lines 29-35 * * page 9, lines 11-14 * * page 10, lines 3-16 * * page 13, lines 20-30 * * page 14, lines 1-9 * * page 15, lines 1-35 * * page 16, lines 7-14 *;
 [Y]US2012171179  (PAK JAEWOO [KR]) [Y] 1-18 * page 2, paragraphs 24, 26 * * page 3, paragraphs 39, 47, 48 * * page 6, paragraphs 90, 101-105 - page 7; example 1 *;
 [Y]WO2014035721  (UNIV TEXAS [US]) [Y] 1-15 * page 4, paragraph 25 * * page 5, paragraphs 26, 27 * * page 6, paragraphs 30, 32 * * page 7, paragraph 35 * * page 8, paragraph 37 * * page 9, paragraph 43 *;
 [Y]CN104587525  (SHENZHEN CHINA CAPTICAL BIOMEDICAL TECHNOLOGY CO LTD) [Y] 1-15 * the whole document *;
 [YP]  - MUN-IK LEE ET AL, "A placebo-controlled study comparing the efficacy of intra-articular injections of hyaluronic acid and a novel hyaluronic acid-platelet-rich plasma conjugate in a canine model of osteoarthritis", JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, (20190918), vol. 14, no. 1, doi:10.1186/s13018-019-1352-1, XP055655871 [YP] 16 * abstract *

DOI:   http://dx.doi.org/10.1186/s13018-019-1352-1
 [Y]  - FABRIZIO RUSSO ET AL, "Platelet Rich Plasma and Hyaluronic Acid Blend for the Treatment of Osteoarthritis: Rheological and Biological Evaluation", PLOS ONE, (20160616), vol. 11, no. 6, doi:10.1371/journal.pone.0157048, pages 1 - 12, XP055625964 [Y] 17 * the whole document *

DOI:   http://dx.doi.org/10.1371/journal.pone.0157048
 [Y]  - Pietro Gentile ET AL, "Use of Platelet Rich Plasma and Hyaluronic Acid in the Treatment of Complications of Achilles Tendon Reconstruction", World journal of plastic surgery, Iran, (20160501), pages 124 - 132, URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003947/pdf/wjps-5-124.pdf, XP055729539 [Y] 18 * abstract *
by applicantWO2009016451
 EP2185163
 US2012171169
 WO2013076160
 WO2014035721
 EP2900247
    - CUPAIOLO RGOVAERTS DBLAUWAERT MCAUCHIE P., "Performance evaluation of a new Stago@ automated haemostasis analyser: The STA R Max@ 2", Int J Lab Hematol., (20190000), vol. 41, no. 6, pages 731 - 737
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.